VDAC1 and progeroid syndrome: In our study, VBIT4 treatment of Z24−/− myofibers in vitro was effective in inhibiting mtDNA-induced cGAS-Sting activation and expression of SASP factors, suggesting that VDAC1 can be a novel molecular target for improving progeria aging-associated defective phenotypes.